| Date Filed | Type | Description |
| 04/29/2019 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 04/17/2019 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 04/17/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/17/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/17/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/17/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/17/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/17/2019 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 04/17/2019 |
GN
| Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc |
| 04/17/2019 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 04/17/2019 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 04/16/2019 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 04/12/2019 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 04/10/2019 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 04/10/2019 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/27/2019 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/27/2019 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/20/2019 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 03/20/2019 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 03/15/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
| 03/14/2019 |
GN
| OSIRIS THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout |
| 03/12/2019 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 03/12/2019 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits |
| 03/12/2019 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 03/12/2019 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 03/12/2019 |
8-K
| Other Events, Financial Statements and Exhibits |
| 02/28/2019 |
GN
| Predictive Technology Group Names Jay M. Moyes to Its Board of Directors |
| 11/26/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/26/2018 |
GN
| Osiris Therapeutics, Inc. Appoints Samson Tom, PhD, MBA to Serve as President and Chief Executive Officer |
| 11/08/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 11/07/2018 |
10-Q
| Quarterly Report for the period ended September 30, 2018 |
| 11/07/2018 |
GN
| Osiris Therapeutics, Inc Reports Third Quarter 2018 Results |
| 10/30/2018 |
GN
| Osiris Therapeutics, Inc. to Present Advanced Clinical and Scientific Abstracts at Symposium on Advanced Wound Care (SAWC) Fall Meeting, November 2-4, 2018, in Las Vegas, Nevada |
| 10/02/2018 |
GN
| Osiris Therapeutics, Inc. Announces Peer-Reviewed Publication Demonstrating That Lyopreservation Method Developed for Living Tissues is an Alternative to Cryopreservation with the Convenience of Ambient Storage |
|